Zolbetuximab plus chemotherapy in Japanese patients with claudin 18.2–positive gastric or gastroesophageal junction adenocarcinoma: a combined subgroup analysis of the phase 3 SPOTLIGHT and GLOW trials
Kensei Yamaguchi, Hirokazu Shoji, Hisateru Yasui, Eiji Oki et autres
jp, us, gb (code pays fourni par la source)
0 citations
Gastric Cancer